BSEZenith Healthcare LtdHighNeutral
Announced Thu, 12 Feb · 18:01 IST

Un-Audited Financial Results For The Quarter Ended On 31St December, 2025

Pat Growth 25pctEbitda Margin ExpansionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Zenith Healthcare reported unaudited results for the quarter ended 31 Dec 2025. Revenue from operations rose to ₹248.30 lakhs, up about 7.7% from ₹230.52 lakhs in Q3 of the previous year. Net profit for the quarter came in at ₹22.41 lakhs (EPS ₹0.042), compared to a loss of ₹29.22 lakhs in the same quarter last year, marking a clear YoY turnaround. For the nine-month period, revenue was nearly flat at ₹790.07 lakhs versus ₹790.44 lakhs, but net profit swung to a surplus of ₹34.71 lakhs from a loss of ₹4.27 lakhs. The improvement was driven mainly by a sharp drop in cost of materials and broadly stable operating expenses. Statutory auditors Doshi Doshi & Co issued an unmodified limited review report with no qualifications.

Likely market impact

The sharp swing back to profit is a positive signal on operational health, but the absolute earnings remain tiny and nine-month revenue is flat, so this is a modest positive rather than a strong re-rating catalyst. Shareholders should watch whether the profit recovery sustains with revenue growth in coming quarters.